Mesoblast (MESO) Return on Equity: 2015-2023
Historic Return on Equity for Mesoblast (MESO) over the last 7 years, with Jun 2023 value amounting to -0.17%.
- Mesoblast's Return on Equity rose 1.00% to -0.17% in Q2 2023 from the same period last year, while for Jun 2023 it was -0.17%, marking a year-over-year increase of 1.00%. This contributed to the annual value of -0.18% for FY2024, which is 2.00% down from last year.
- Latest data reveals that Mesoblast reported Return on Equity of -0.17% as of Q2 2023, which was down 0.42% from -0.17% recorded in Q1 2023.
- Over the past 5 years, Mesoblast's Return on Equity peaked at -0.15% during Q2 2020, and registered a low of -0.22% during Q2 2019.
- Moreover, its 3-year median value for Return on Equity was -0.17% (2022), whereas its average is -0.17%.
- Per our database at Business Quant, Mesoblast's Return on Equity fell by 4bps in 2019 and then increased by 7bps in 2020.
- Quarterly analysis of 5 years shows Mesoblast's Return on Equity stood at -0.19% in 2019, then rose by 2bps to -0.17% in 2020, then remained steady at -0.18% in 2021, then climbed by 1bps to -0.16% in 2022, then climbed by 1bps to -0.17% in 2023.
- Its last three reported values are -0.17% in Q2 2023, -0.17% for Q1 2023, and -0.16% during Q4 2022.